Imeik Technology Development Co

Imeik Technology Development Co Diluted EPS

The Diluted Earnings per Share of Imeik Technology Development Co (300896.SZ) as of Oct 19, 2026 is 4.28 CNY. In the previous year, Diluted Earnings per Share was 6.52 CNY — a change of -34.28% (lower).

Diluted EPS

4.28CNY

YoY

-34.28%

Last updated:

Diluted Earnings per Share of Imeik Technology Development Co is 2025 4.28 CNY. Diluted Earnings per Share of Imeik Technology Development Co was 2024 6.52 CNY. It decreases by -34.28% lower compared to the previous year.

The Imeik Technology Development Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
0.41 CNY
Jan 1, 2019
1.34 CNY
Jan 1, 2020
1.48 CNY
Jan 1, 2021
3.16 CNY
Jan 1, 2022
4.17 CNY
Jan 1, 2023
6.18 CNY
Jan 1, 2024
6.52 CNY
Jan 1, 2025
4.28 CNY
The Imeik Technology Development Co Diluted EPS history
YEARDiluted EPSYoY
4.28CNY-34.28%
6.52CNY+5.44%
6.18CNY+48.12%
4.17CNY+32.09%
3.16CNY+113.12%
1.48CNY+10.92%
1.34CNY+227.87%
0.41CNY+49.47%
0.27CNY+53.99%
0.18CNY+202.38%
0.06CNY-37.89%
0.09CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Imeik Technology Development Co Stock analysis

What does Imeik Technology Development Co do? Imeik Technology Development Co Ltd is a biotechnology company based in Beijing, China, operating within the healthcare sector. The company focuses on the research, development, and industrialization of biomedical materials, particularly recombinant proteins and peptides. It has established a product technology transformation platform for biomedical materials, including medical chitosan and polylactic acid. Imeik has successfully industrialized injection-type sodium hyaluronate series products and polydioxanone facial implants. Its self-developed products are primarily designed for the repair of facial and neck skin folds, with clinical applications spanning medical cosmetology, surgical repair, and the treatment of metabolic diseases. The company went public on the Shenzhen Stock Exchange on September 28, 2020, with ticker 300896.SZ and ISIN CNE100004868. Imeik currently employs 713 full-time staff and operates exclusively within the Chinese market. Its website is www.imeik.net, providing information on its products and services. The company emphasizes the development and transformation of biomedical materials, aiming to advance biomedicine through its specialized focus on recombinant proteins and peptides. It has developed a range of products that address specific medical and cosmetic needs, contributing to its position in the healthcare industry. Imeik Technology Development Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imeik Technology Development Co stock

Diluted Earnings per Share of Imeik Technology Development Co is 4.28 CNY in 2025.

Diluted Earnings per Share of Imeik Technology Development Co changed from 6.52 CNY to 4.28 CNY, representing a -34.28% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Imeik Technology Development Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Imeik Technology Development Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Imeik Technology Development Co